|
|
|
|
Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases
Positive Phase 2 trial results of Keryx Biopharmaceuticals' KRX-0401 announcedKeryx Biopharmaceuticals, Inc.(the "Company") today announced that an article entitled "Clinical an...Phase III clinical trial evaluating darusentan misses its co-primary efficacy...
|
|
|
UPDATE 3-Cephalon to buy generic firm Mepha for $590 mln
* Cephalon expands into generic drug business * Mepha acquisition to add to 2010 earnings * Cephalon shares rise 1.5 percent (Updates with analyst comment, CEO comment, share price ) BOSTON, Feb 1 (Reuters) - U.S.drugmaker Cephalon Inc <CEPH.O> said on...
|
|
|
Cephalon to buy generic firm Mepha for $590 million
BOSTON (Reuters) - U.S.drugmaker Cephalon Inc (CEPH.O) said on Monday it will buy Mepha AG, the Swiss generic drugmaker owned by Germany's Merckle family, for about $590 million (622.5 million Swiss francs) to diversify its product line and expand...
|
|
|
UPDATE 3-Cephalon to buy generic firm Mepha for $590 mln
* Mepha acquisition to add to 2010 earnings * Cephalon shares rise 1.5 percent (Updates with analyst comment, CEO comment, share price ) BOSTON, Feb 1 (Reuters) - U.S.drugmaker Cephalon Inc (CEPH.O: Quote, Profile, Research) said on Monday it will buy Mepha...
|
|
|
Bendamustine-R Is Potential New Standard for
New OrleansThe combination of bendamustine (Treanda, Cephalon) and rituximab (Rituxan, Biogen Idec/Genentech) is better tolerated and more effective than the current standard of CHOP-R (cyclophosphamide, hydroxydaunorubicin, Oncovin and prednisolone plus...
|
|
|
Misleading Treanda Statements Draw Untitled Letter
A pocket dosing card for Cephalons cancer drug Treanda omits important risk inf Misleading Treanda Statements Draw Untitled Letter.
|
|
|
FDA cites Lilly, other drugmakers for promo materials, ads
WASHINGTON?Federal health regulators have issued enforcement letters to Eli Lilly, Bayer, Amylin Pharmaceuticals and Cephalon for making inaccurate or incomplete statements while promoting their drugs? The Food and Drug Administration last week disclosed...
|
|
|
FDA letters cite Lilly, Bayer, Amylin, Cephalon
Federal health regulators have issued enforcement letters to Indianapolis drugmaker Eli Lilly and Co., as well as Bayer, Amylin Pharmaceuticals and Cephalon, for making inaccurate or incomplete statements while promoting their drugs.The Food and Drug...
|
|
|
Cephalon stops using Treanda dosing cards after FDA letter calls them misleading
The Food and Drug Administration said it has issued a letter of notification to Cephalon Inc.concerning part of the promotional material used with its cancer drug Treanda. The FDA said the pocket dosing card is false or misleading because it omits...
|
|
|
FDA Letters Cite Lilly, Bayer, Amylin and Cephalon
MATTHEW PERRONE AP Business Writer WASHINGTON (AP) ' Federal health regulators have issued enforcement letters to Eli Lilly, Bayer, Amylin Pharmaceuticals and Cephalon for making inaccurate or incomplete statements while promoting their drugs.The Food and...
|
|
|
FDA Warnings Issued Over Drug Company Marketing
The Food Drug Administration has issued warning letters to various drug companies over their promotional materials making inaccurate or incomplete claims.The Los Angeles Times reports that the FDA warnings involve drug company marketing from Eli Lilly, Bayer...
|
|
|
Health highlights: Jan. 13, 2010
Traffic Pollution Harms Lungs, Heart: Study Traffic pollution has a major impact on lung and heart health, says a report to be released Wednesday by the nonprofit Health Effects Institute in Boston.Researchers analyzed 700 international studies and found ...
|
|
|
Health highlights: Jan. 13, 2010
Traffic Pollution Harms Lungs, Heart: Study Traffic pollution has a major impact on lung and heart health, says a report to be released Wednesday by the nonprofit Health Effects Institute in Boston.Researchers analyzed 700 international studies and found ...
|
|
|
Cephalon Gets Untitled Letter for Misleading Treanda Statements
ePublishing :: CMS, Hosting & Web Development | Copyright by FDAnews All right Cephalon Gets Untitled Letter for Misleading Treanda Statements.
|
|
|
FDA letters cite Lilly, Bayer, Amylin and Cephalon
4:31 PM EST More Las Vegas News By MATTHEW PERRONEAP Writer WASHINGTON (AP) - Federal health regulators have issued enforcement letters to Eli Lilly, Bayer, Amylin Pharmaceuticals and Cephalon for making inaccurate or incomplete statements while promoting their...
|
|
|
Health highlights: Jan. 13, 2010
Traffic Pollution Harms Lungs, Heart: Study Traffic pollution has a major impact on lung and heart health, says a report to be released Wednesday by the nonprofit Health Effects Institute in Boston.Researchers analyzed 700 international studies and found ...
|
|
|
Cephalon stops using Treanda dosing cards after FDA letter calls them misleading
The Food and Drug Administration said it has issued a letter of notification to Cephalon Inc.concerning part of the promotional material used with its cancer drug Treanda. The FDA said the pocket dosing card is false or misleading because it omits...
|
|
|
Cephalon stops using Treanda dosing cards after FDA letter calls them misleading
The said it has issued a letter of notification to Cephalon Inc.concerning part of the promotional material used with its cancer drug Treanda. The FDA said the pocket dosing card is false or misleading because it omits important risk information...
|
|
|
FDA Warns Bayer, Eli Lilly For Misleading Drug Ads (DJ)
By Jared A.Favole Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration has warned several pharmaceutical companies, including Eli Lilly & Co. (LLY) and Bayer AG (BAYRY, BAYN.XE), for either overstating the...
|
|
|
FDA issues warning letters to drug companies for misleading ads
ROCKVILLE,Md.(Jan. 13) Four drug companies have received warnings from the Food and Drug Administration in the last month for what the agency calls misleading direct-to-consumer advertisements and WebMD Blue Book messages, according to letters the FDA...
|
|
|
FDA letters cite Lilly, Bayer, Amylin and Cephalon
Federal health regulators have issued enforcement letters to Eli Lilly, Bayer, Amylin Pharmaceuticals and Cephalon for making inaccurate or incomplete statements while promoting their drugs.The Food and Drug Administration on Tuesday disclosed four letters...
|
|
|
FDA letters cite Lilly, Bayer, Amylin and Cephalon
WASHINGTON Federal health regulators have issued enforcement letters to Eli Lilly, Bayer, Amylin Pharmaceuticals and Cephalon for making inaccurate or incomplete statements while promoting their drugs.The Food and Drug Administration on Tuesday disclosed...
|
|
|
Cephalon stops using Treanda dosing cards after FDA letter calls them misleading
The Food and Drug Administration said it has issued a letter of notification to Cephalon stops using Treanda dosing cards after FDA letter calls them misleading.
|
|
|
FDA letters cite Lilly, Bayer, Amylin and Cephalon
WASHINGTON Federal health regulators have issued enforcement letters to Eli Lilly, Bayer, Amylin Pharmaceuticals and Cephalon for making inaccurate or incomplete statements while promoting their drugs.Latest Health Care News Current Edition The Food and Drug...
|
|
|
FDA letters cite four drug companies
The FDA regularly issues letters to companies that do not Warned against inaccurate promotion statements Published : Tuesday, 12 Jan 2010, 4:45 PM EST MATTHEW PERRONE WASHINGTON (AP) - Federal health regulators have issued enforcement letters to Eli Lilly,...
|
